Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedGlossary toggle added (Show glossary) and study record metadata updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; legacy labels and prior revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter changes: the HHS Vulnerability Disclosure link was removed and the Revision: v3.3.3 tag was added. These changes are limited to footer and metadata and do not affect the study content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.2 is shown, replacing the previous v3.3.1. This appears to be a minor frontend update that does not alter study details or functionality.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded clarifications that publications are provided voluntarily and are automatically filled from PubMed, and noted Revision: v3.3.1. The prior language implying PubMed articles are automatically generated and may relate to the study results was removed.SummaryDifference0.2%

- Check76 days agoChange DetectedRemoval of the government funding status notice at the bottom of the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.